Personalized medicine means targeting the right treatment to the right patient. It encompasses pairing state-of-the-art diagnostics with drug development and raises issues related to bioethics, reimbursement, professional and patient education, regulation, and public policy. This book, published by The Food and Drug Law Institute in partnership with the American Association for the Advancement of Science, discusses these facets of personalized medicine in an accessible, user-friendly way. The book is designed for professionals in all areas of the healthcare industry, to give a broad-based understanding of the scope, impact and reach of personalized medicine as well as of the challenges that lie ahead as we move forward into this exciting new era of medical care.
||Joanne Hawana and Deborah Runkle, Editors
|Number of pages:
||Apr 01, 2011